MPO and glioblastoma: Compared with the other two groups, the patients in the DPPs group were older with an average age of 64.50 ± 9.77 years, and the patients in the anti-GBM group were the youngest (p < 0.05, MPO-AAV vs. DPPs; p < 0.05, DPPs vs. anti-GBM).